• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 相关头痛的模式:一项横断面研究。

Patterns of COVID-19-related headache: A cross-sectional study.

机构信息

Kirsehir Ahi Evran University Faculty of Medicine, Department of Neurology, Kirsehir, Turkey.

Kirsehir Ahi Evran University Faculty of Medicine, Department of Clinical Microbiology and Infectious Diseases, Kirsehir, Turkey.

出版信息

Clin Neurol Neurosurg. 2022 Aug;219:107339. doi: 10.1016/j.clineuro.2022.107339. Epub 2022 Jun 14.

DOI:10.1016/j.clineuro.2022.107339
PMID:35753162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9192353/
Abstract

BACKGROUND

Headache is the most common COVID-19-related neurological symptom. We investigated the characteristics of COVID-19-related headache and their relationship with clinical severity in Kırşehir Province, Turkey.

METHODS

This cross-sectional study prospectively enrolled 226 COVID-19-positive patients who developed headache during acute infection. Demographic data, headache characteristics, and infection symptoms were recorded. The clinical severity of COVID-19 was documented in each participant.

RESULT

New-onset COVID-19-related headaches lasting 4 days were reported in 164 patients (72.5 %); these were mostly bilaterally or localized to the forehead (58.4 %), pulsating (42.5 %), moderate to severe intensity (30.1 %), with a partial response to paracetamol (23.5 %). The other 62 patients (27.4 %) reported headaches before COVID-19. Their COVID-related headaches were fiery type (p = 0.025), of very severe intensity (p = 0.008), had a holocranial distribution (p = 0.004), and were less response to paracetamol (p = 0.003); the headaches were significantly more frequent after COVID-19 than before COVID-19. Older age, high body mass index, and low education level were significantly higher in the severe group (all p < 0.001). Female sex (p = 0.019) and being a healthcare worker (p < 0.001) were significantly more frequent in mild cases.

CONCLUSIONS

Bilateral, prolonged, moderate to severe headaches that were analgesic resistant are more frequent in patients with COVID-19 infection. Further study should examine whether the headache characteristics distinguish COVID-19-related headaches from other types, particularly in asymptomatic subjects.

摘要

背景

头痛是 COVID-19 相关的最常见神经症状。我们在土耳其克尔谢希尔省调查了 COVID-19 相关头痛的特征及其与临床严重程度的关系。

方法

这项横断面研究前瞻性纳入了 226 名急性感染期间出现头痛的 COVID-19 阳性患者。记录了人口统计学数据、头痛特征和感染症状。每位参与者的 COVID-19 临床严重程度都有记录。

结果

164 名患者(72.5%)报告了新发持续 4 天的 COVID-19 相关头痛;这些头痛大多是双侧或局限于额头(58.4%)、搏动性(42.5%)、中重度强度(30.1%),对扑热息痛有部分反应(23.5%)。另外 62 名患者(27.4%)在 COVID-19 之前报告了头痛。他们的 COVID 相关头痛为火热型(p=0.025),强度非常严重(p=0.008),全颅分布(p=0.004),对扑热息痛的反应较差(p=0.003);COVID-19 后头痛的发生频率明显高于 COVID-19 前。严重组的年龄较大(p<0.001)、身体质量指数较高(p<0.001)、受教育程度较低(p<0.001)。轻度组中女性(p=0.019)和医务人员(p<0.001)的比例明显更高。

结论

COVID-19 感染患者更常出现双侧、持续时间长、中重度、对镇痛药有抵抗性的头痛。进一步的研究应检查头痛特征是否能将 COVID-19 相关头痛与其他类型的头痛区分开来,特别是在无症状人群中。

相似文献

1
Patterns of COVID-19-related headache: A cross-sectional study.COVID-19 相关头痛的模式:一项横断面研究。
Clin Neurol Neurosurg. 2022 Aug;219:107339. doi: 10.1016/j.clineuro.2022.107339. Epub 2022 Jun 14.
2
Headache as a Cardinal Symptom of Coronavirus Disease 2019: A Cross-Sectional Study.头痛为 2019 冠状病毒病的主要症状:一项横断面研究。
Headache. 2020 Nov;60(10):2176-2191. doi: 10.1111/head.13967. Epub 2020 Sep 28.
3
Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6.潜伏类群聚类分析确定了 COVID-19 中的隐匿性头痛表型:肺浸润和 IL-6 的影响。
Neurol Sci. 2021 May;42(5):1665-1673. doi: 10.1007/s10072-020-04978-2. Epub 2021 Feb 9.
4
New daily persistent headache after SARS-CoV-2 infection in Latin America: a cross-sectional study.新型冠状病毒感染后新发持续性每日头痛:一项横断面研究。
BMC Infect Dis. 2023 Dec 14;23(1):877. doi: 10.1186/s12879-023-08898-2.
5
Spectrum of Headaches Associated With SARS-CoV-2 Infection: Study of Healthcare Professionals.与 SARS-CoV-2 感染相关的头痛谱:医护专业人员研究。
Headache. 2020 Sep;60(8):1697-1704. doi: 10.1111/head.13902. Epub 2020 Jul 15.
6
Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.COVID-19 患者的头痛、嗅觉丧失、味觉丧失和其他神经系统症状:一项横断面研究。
J Headache Pain. 2022 Jan 3;23(1):2. doi: 10.1186/s10194-021-01367-8.
7
Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review.与 SARS-CoV-2 感染和疫苗接种相关的头痛和面部疼痛:系统评价。
Eur J Neurol. 2024 Jun;31(6):e16251. doi: 10.1111/ene.16251. Epub 2024 Feb 28.
8
Headache characteristics in COVID-19 pandemic-a survey study.新冠疫情期间的头痛特征:一项调查研究。
J Headache Pain. 2020 Oct 13;21(1):121. doi: 10.1186/s10194-020-01188-1.
9
High Prevalence of Headaches During Covid-19 Infection: A Retrospective Cohort Study.新冠感染期间头痛的高发率:一项回顾性队列研究。
Headache. 2020 Nov;60(10):2578-2582. doi: 10.1111/head.13923. Epub 2020 Aug 5.
10
COVID-19 is a Real Headache!COVID-19 真是让人头疼!
Headache. 2020 Jul;60(7):1415-1421. doi: 10.1111/head.13856. Epub 2020 May 27.

引用本文的文献

1
A comparison study of headache characteristics and headache-associated quality-of-life of COVID-19 and non-COVID-19 patients.新冠病毒感染患者与非新冠病毒感染患者头痛特征及头痛相关生活质量的比较研究
Narra J. 2022 Dec;2(3):e93. doi: 10.52225/narra.v2i3.93. Epub 2022 Dec 10.

本文引用的文献

1
Neurological consequences of COVID-19 and brain related pathogenic mechanisms: A new challenge for neuroscience.新型冠状病毒肺炎的神经学后果及脑相关致病机制:神经科学面临的新挑战
Brain Behav Immun Health. 2022 Feb;19:100399. doi: 10.1016/j.bbih.2021.100399. Epub 2021 Nov 30.
2
Neurological symptoms of COVID-19 infection; a cross-sectional study on hospitalized COVID-19 patients in Iran.新型冠状病毒感染的神经系统症状;伊朗住院的新型冠状病毒肺炎患者的横断面研究。
Clin Neurol Neurosurg. 2021 Nov;210:106985. doi: 10.1016/j.clineuro.2021.106985. Epub 2021 Oct 11.
3
Headaches associated with acute SARS-CoV-2 infection: A prospective cross-sectional study.与急性SARS-CoV-2感染相关的头痛:一项前瞻性横断面研究。
SAGE Open Med. 2021 Oct 7;9:20503121211050227. doi: 10.1177/20503121211050227. eCollection 2021.
4
Selective Vagus Nerve Stimulation as a Therapeutic Approach for the Treatment of ARDS: A Rationale for Neuro-Immunomodulation in COVID-19 Disease.选择性迷走神经刺激作为治疗急性呼吸窘迫综合征的一种治疗方法:COVID-19疾病中神经免疫调节的理论依据。
Front Neurosci. 2021 Apr 13;15:667036. doi: 10.3389/fnins.2021.667036. eCollection 2021.
5
Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients.根据 COVID-19 严重程度的流行病学、耳鼻喉科、嗅觉和味觉结果:一项 2579 例患者的研究。
Eur Arch Otorhinolaryngol. 2021 Aug;278(8):2851-2859. doi: 10.1007/s00405-020-06548-w. Epub 2021 Jan 16.
6
Headache characteristics in COVID-19 pandemic-a survey study.新冠疫情期间的头痛特征:一项调查研究。
J Headache Pain. 2020 Oct 13;21(1):121. doi: 10.1186/s10194-020-01188-1.
7
Headache as a Cardinal Symptom of Coronavirus Disease 2019: A Cross-Sectional Study.头痛为 2019 冠状病毒病的主要症状:一项横断面研究。
Headache. 2020 Nov;60(10):2176-2191. doi: 10.1111/head.13967. Epub 2020 Sep 28.
8
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19.血清 CCL17 水平成为区分 COVID-19 患者轻症/中症和重症/危重症的预测标志物。
Gene. 2021 Jan 15;766:145145. doi: 10.1016/j.gene.2020.145145. Epub 2020 Sep 14.
9
Spectrum of Headaches Associated With SARS-CoV-2 Infection: Study of Healthcare Professionals.与 SARS-CoV-2 感染相关的头痛谱:医护专业人员研究。
Headache. 2020 Sep;60(8):1697-1704. doi: 10.1111/head.13902. Epub 2020 Jul 15.
10
Neurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis.2019年冠状病毒病(COVID-19)的神经学特征:系统评价与荟萃分析
Front Neurol. 2020 May 29;11:565. doi: 10.3389/fneur.2020.00565. eCollection 2020.